Bioverge, Inc. — Form D
Bioverge, Inc. of San Francisco, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-05-04. The offering totals $600K, of which $589K was reported sold. Industry: Other Technology.
Offering
- Filed: 2023-05-04
- Form: D
- Accession: 0001786236-23-000004
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $600K
- Amount sold: $589K
- Remaining: $12K
- Minimum investment: $5K
- Investors: 23
- Date of first sale: 2018-12-03
- Revenue range: Decline to Disclose
- SEC file number: 021-480857
Issuer
- Name: Bioverge, Inc.
- CIK: 0001828649
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 447 Sutter St. Ste 405, San Francisco, CA, 94108
- Phone: 8664151001
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Neil Littman | Director | San Francisco, CA |
| Neil Littman | Executive Officer | San Francisco, CA |
| Richard Gibb | Executive Officer | San Francisco, CA |
Other filings by this issuer (2)
More